Before surgery, a biopsy gene test could reveal which lung tumors are likely to recur

Lung cancer is the leading cause of death from cancer. It kills more people in the U.S. than breast, prostate, and colon cancer combined. When lung adenocarcinoma, the most common primary lung cancer in the U.S., grows into nearby blood vessels (a process called vascular invasion), the tumor is more likely to recur even if surgically removed. Pathologists can identify areas of vascular invasion post-operatively, but surgeons could perform more extensive surgery to lower the risk of recurrence if they could predict which tumors were more likely to have vascular invasion.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup